Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
2009
Polyzos, S. A., & Anastasilakis A. D. (2009).  Clinical complications following thyroid fine-needle biopsy: a systematic review.. Clin Endocrinol (Oxf). 71(2), 157-65.
Polyzos, S. A., Patsiaoura K., & Zachou K. (2009).  Histological alterations following thyroid fine needle biopsy: a systematic review.. Diagn Cytopathol. 37(6), 455-65.
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways.. Med Hypotheses. 72(5), 610.
Anastasilakis, A. D., Goulis D. G., Polyzos S. A., Gerou S., Ballaouri I., Efstathiadou Z., et al. (2009).  No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.. Clin Endocrinol (Oxf). 70(4), 522-6.
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.. Curr Mol Med. 9(3), 299-314.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2009).  Paget's disease of bone: emphasis on treatment with zoledronic acid.. Expert Rev Endocrinol Metab. 4(5), 423-434.
Anastasilakis, A. D., Toulis K. A., Polyzos S. A., & Terpos E. (2009).  RANKL inhibition for the management of patients with benign metabolic bone disorders.. Expert Opin Investig Drugs. 18(8), 1085-102.
Polyzos, S. A., Anastasilakis A. D., & Terpos E. (2009).  Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.. Support Care Cancer. 17(10), 1329-30.
2008
Anastasilakis, A. D., Goulis D. G., Polyzos S. A., Gerou S., Pavlidou V., Koukoulis G., et al. (2008).  Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatide.. Eur J Endocrinol. 158(3), 411-5.
Anastasilakis, A. D., Polyzos S. A., Goulis D. G., Slavakis A., Efstathiadou Z., Kita M., et al. (2008).  Endogenous intact PTH is suppressed during Teriparatide (rhPTH 1-34) administration in postmenopausal women with established osteoporosis.. Endocr J. 55(3), 613-6.
Avramidis, A., Polyzos S. A., Moralidis E., Arsos G., Efstathiadou Z., Karakatsanis K., et al. (2008).  Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.. J Bone Miner Metab. 26(6), 635-41.
Polyzos, S. A., Kita M., Efstathiadou Z., Poulakos P., Slavakis A., Sofianou D., et al. (2008).  Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.. J Cancer Res Clin Oncol. 134(9), 953-60.
Anastasilakis, A. D., Polyzos S. A., & Nikolopoulos P. (2008).  Subendothelial carotid hematoma after fine-needle aspiration biopsy of a solitary thyroid nodule.. J Ultrasound Med. 27(10), 1517-20.
Avramidis, A., Polyzos S. A., Efstathiadou Z., & Kita M. (2008).  Sustained clinical inactivity and stabilization of GH/IGF-1 levels in an acromegalic patient after discontinuation of somatostatin analogue treatment.. Endocr J. 55(2), 351-7.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.